Evidence map›Paper›PMID 37666956›Full record

ArticleBone marrow transplantation2023

Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic.

Eugenio Galli, Alice Di Rocco, Ilaria Pansini, Federico Frondizi, Martina Di Palma, Elisabetta Metafuni, Nicola Piccirillo, Maria Bianchi, Antonella Cingolani, Giovanni Fernando Torelli and 6 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Eugenio Galli *Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-2839-916X
Alice Di Rocco *Dipartimento di Medicina Traslazionale e di Precisione, Università di Roma Sapienza, Rome, Italy.
Ilaria PansiniSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Federico FrondiziDipartimento di Sicurezza e Bioetica, Università Cattolica del Sacro Cuore, Rome, Italy.
Martina Di PalmaDipartimento di Medicina Traslazionale e di Precisione, Università di Roma Sapienza, Rome, Italy.
Elisabetta MetafuniDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-4780-1273
Nicola PiccirilloDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-1688-1987
Maria BianchiDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Antonella CingolaniDipartimento di Sicurezza e Bioetica, Università Cattolica del Sacro Cuore, Rome, Italy.
Giovanni Fernando TorelliDipartimento di Medicina Traslazionale e di Precisione, Università di Roma Sapienza, Rome, Italy.
Stefan HohausDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Patrizia ChiusoloDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-1355-1587
Anna Paola IoriDipartimento di Medicina Traslazionale e di Precisione, Università di Roma Sapienza, Rome, Italy.
Simona SicaDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. simona.sica@unicatt.it.ORCID http://orcid.org/0000-0003-2426-3465
Maurizio MartelliDipartimento di Medicina Traslazionale e di Precisione, Università di Roma Sapienza, Rome, Italy.
Federica SoràDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-9607-5298
Università Cattolica del Sacro Cuore · ITSapienza University of Rome · ITAgostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Receptors, Chimeric AntigenAntibodies, MonoclonalCOVID-19 VaccinesHumansPandemicsSARS-CoV-2VaccinationAntibodies, MonoclonalcilgavimabCOVID-19 VaccinesReceptors, Chimeric Antigentixagevimab

Identifiers

PMID37666956
OpenAlexW4386421976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.